Currently, there are no recommendations regarding how long a patient can remain on Semaglutide or Tirzepatide therapy
Research published in the American Journal of Clinical Nutrition shows that up to 40% of total weight loss on GLP-1 receptor agonists can come from lean mass, not fat
The findings suggest semaglutide may be a preferred choice of GLP-1 RA for reducing cardiovascular risk in type 2 diabetes, offering clinicians valuable evidence to guide therapeutic decisions
Unlike traditional pharmacies youre familiar with that supply FDA-approved medications made by pharmaceutical companies, compounding pharmacies create customized medications from scratch for patients that need them, says Tenille Davis, PharmD, a pharmacist and the chief advocacy officer for the Alliance for Pharmacy Compounding, an advocacy group for compounding pharmacists
These basic studies provide a solid theoretical basis for the treatment of kidney diseases and provide valuable information for the prevention and treatment of primary renal diseases and kidney complications
